NRobotics Co

NRobotics Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of NRobotics Co (138360.KQ) as of Nov 12, 2026 is -170.06. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -73.24 — a change of 132.19% (lower).

EV/EBITDA

-170.06

YoY

132.19%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of NRobotics Co is 2024 -170.06 . EV/EBITDA (Enterprise Value to EBITDA) of NRobotics Co was 2023 -73.24 . It decreases by 132.19% lower compared to the previous year.

The NRobotics Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2017
415.77 KRW
Jan 1, 2018
-59.09 KRW
Jan 1, 2019
892.28 KRW
Jan 1, 2020
-46.08 KRW
Jan 1, 2021
208.46 KRW
Jan 1, 2022
128.44 KRW
Jan 1, 2023
-73.24 KRW
Jan 1, 2024
-170.06 KRW
The NRobotics Co EV/EBITDA history
YEAREV/EBITDAYoY
-170.06+132.19%
-73.24-157.02%
128.44-38.39%
208.46-552.45%
-46.08-105.16%
892.28-1,609.93%
-59.09-114.21%
415.77+694.11%
52.36-50.87%
106.57+172.67%
39.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NRobotics Co Stock analysis

What does NRobotics Co do? Hyupjin Co., Ltd. generates revenue through the manufacture and sale of cosmetic ingredients, including bioconversion technology products, encapsulated products, natural extracts, and synthetic products. Key products such as Aquatouch L, Silkytouch L, Phytoact Reliefer, PhytoAct CosyPlex, Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage are sold to clients in the cosmetics industry. The company provides electronic materials as part of its product portfolio, targeting manufacturers seeking high-quality cosmetic ingredients and materials for their formulations. Hyupjin Co., Ltd. focuses on delivering specialized cosmetic ingredients through its range of products, with each product composed of specific ingredients like glycerin, dimethicone, water, lecithin, and various plant extracts. The company’s offerings cater to the needs of cosmetic manufacturers who require advanced formulations for skincare and beauty products. Its product lineup includes both natural and synthetic options, supporting diverse applications in the beauty sector. The company’s product portfolio includes Aquatouch L, Silkytouch L, and multiple Actosome series products, all designed to meet the demands of cosmetic manufacturers. These products are formulated with ingredients such as phaseolus radiates seed extract, avena sativa meal extract, and ethyhexylglycerin, among others. Hyupjin Co., Ltd. serves the cosmetics industry by providing ingredients that enhance product performance and consumer appeal, leveraging its bioconversion technology and natural extract expertise. NRobotics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NRobotics Co stock

EV/EBITDA (Enterprise Value to EBITDA) of NRobotics Co is -170.06 in 2024.

EV/EBITDA (Enterprise Value to EBITDA) of NRobotics Co changed from -73.24 to -170.06, representing a 132.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) NRobotics Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s NRobotics Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — NRobotics Co

All Key Metrics — NRobotics Co